Birdwatch Note
2024-08-15 15:44:40 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
This claim lacks supporting evidence. Ivermectin may have cytotoxic and immunomodulating properties as suggested in several in vitro and animal studies, but no convincing human trials have been conducted. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505114/
Written by 8572837E20B5329874D7120CA3B2275A460678F4709885946383D00B09BB502A
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1823887706646040585
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1824109964656263347
- noteId - 1824109964656263347
- participantId -
- noteAuthorParticipantId - 8572837E20B5329874D7120CA3B2275A460678F4709885946383D00B09BB502A
- createdAtMillis - 1723736680556
- tweetId - 1823887706646040585
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- This claim lacks supporting evidence. Ivermectin may have cytotoxic and immunomodulating properties as suggested in several in vitro and animal studies, but no convincing human trials have been conducted. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505114/
Note Ratings
| rated at | rated by | |
| 2024-08-16 15:55:16 -0500 | Rating Details | |
| 2024-08-16 15:25:49 -0500 | Rating Details | |
| 2024-08-16 15:17:08 -0500 | Rating Details | |
| 2024-08-16 15:08:43 -0500 | Rating Details | |
| 2024-08-16 13:56:58 -0500 | Rating Details | |
| 2024-08-16 13:19:18 -0500 | Rating Details | |
| 2024-08-16 12:57:22 -0500 | Rating Details | |
| 2024-08-16 11:21:11 -0500 | Rating Details | |
| 2024-08-16 09:43:19 -0500 | Rating Details | |
| 2024-08-16 09:00:58 -0500 | Rating Details | |
| 2024-08-16 08:46:04 -0500 | Rating Details | |
| 2024-08-16 08:46:01 -0500 | Rating Details | |
| 2024-08-16 07:24:57 -0500 | Rating Details | |
| 2024-08-16 06:48:52 -0500 | Rating Details | |
| 2024-08-16 06:45:21 -0500 | Rating Details | |
| 2024-08-16 05:39:12 -0500 | Rating Details | |
| 2024-08-16 05:38:51 -0500 | Rating Details | |
| 2024-08-16 03:29:45 -0500 | Rating Details | |
| 2024-08-16 03:00:58 -0500 | Rating Details | |
| 2024-08-16 02:31:29 -0500 | Rating Details | |
| 2024-08-16 02:18:04 -0500 | Rating Details | |
| 2024-08-16 01:58:55 -0500 | Rating Details | |
| 2024-08-16 01:54:00 -0500 | Rating Details | |
| 2024-08-16 00:53:28 -0500 | Rating Details | |
| 2024-08-15 21:21:53 -0500 | Rating Details | |
| 2024-08-15 18:56:48 -0500 | Rating Details | |
| 2024-08-15 18:33:54 -0500 | Rating Details | |
| 2024-08-15 18:21:18 -0500 | Rating Details | |
| 2024-08-15 17:47:32 -0500 | Rating Details | |
| 2024-08-15 14:39:27 -0500 | Rating Details | |
| 2024-08-15 12:41:19 -0500 | Rating Details | |
| 2024-08-15 12:18:53 -0500 | Rating Details | |
| 2024-08-15 12:18:40 -0500 | Rating Details | |
| 2024-08-15 11:49:36 -0500 | Rating Details | |
| 2024-08-16 22:37:35 -0500 | Rating Details | |
| 2024-08-16 16:33:49 -0500 | Rating Details | |
| 2024-08-16 14:19:10 -0500 | Rating Details | |
| 2024-08-16 13:33:36 -0500 | Rating Details | |
| 2024-08-16 11:31:44 -0500 | Rating Details | |
| 2024-08-16 05:39:53 -0500 | Rating Details | |
| 2024-08-16 03:22:28 -0500 | Rating Details | |
| 2024-08-16 02:27:03 -0500 | Rating Details | |
| 2024-08-15 23:22:44 -0500 | Rating Details | |
| 2024-08-15 18:21:33 -0500 | Rating Details | |
| 2024-08-15 12:30:22 -0500 | Rating Details |